Showing 30 of 3541 posts
Bango hits $2.3m Cash EBITDA as ARR jumps 30% to $18.2m. Profits turn positive as higher-margin platform revenues drive a 600bps gross margin expansion.
JoshuaJanuary 20, 2026
Concurrent Technologies expects strong FY25 growth with record £47m order intake, boosted by a flagship $6.2m defence design services contract. Momentum builds for FY26.
JoshuaJanuary 20, 2026
Midwich Group reports H2 return to growth, profits on target for 2025. Steady margins and strong cash flow, with UK&I leading performance.
JoshuaJanuary 20, 2026
Ibstock PLC reports FY25 revenue growth to £372m, a robust balance sheet post-disposals, and strategic investments poised for market recovery. Steady performance in a challenging environment.
JoshuaJanuary 20, 2026
PPHC reports strong FY2025 results with 24.7% revenue growth, EBITDA ahead of expectations, and solid organic performance.
JoshuaJanuary 20, 2026
Insight into Wise's stellar Q3: 26% volume jump, 20% more customers, and solid margins with dual listing on track.
JoshuaJanuary 20, 2026
System1's Q3 update shows platform revenue rebounds, maintains FY26 guidance despite mixed headline figures.
JoshuaJanuary 20, 2026
Kromek's H1 revenue surged 300% and swung to a £3.1m profit, driven by its transformative Siemens Healthineers deal and strong 71.7% margins.
JoshuaJanuary 20, 2026
Craneware's H1 FY26 shows strong growth: revenue up 6% and EBITDA rising double-digit to $33.4m, with robust cash flow.
JoshuaJanuary 20, 2026
Eagle Eye lifts FY26 profit guidance after strong H1, driven by cost efficiency and higher-margin SaaS revenue. First OEM deals secured.
JoshuaJanuary 20, 2026
Informa and DWTC launch inD, aiming for $650m+ revenue and 30%+ margins in IMEA by 2026. A strategic, capital-light venture.
JoshuaJanuary 20, 2026
Creo Medical's FY25 results show a 50% revenue surge to £6m and a >40% cut in operating loss, marking major steps toward profitability.
JoshuaJanuary 20, 2026
Team Internet Group's FY25 earnings exceed forecasts as strategic DIS sale progresses, potentially boosting market value.
JoshuaJanuary 20, 2026
Staffline's FY 2025 trading update shows profits surging 42% above forecasts, driven by a successful pure-play recruitment pivot and record Q4 hours.
JoshuaJanuary 20, 2026
Yü Group reports steady FY25 growth with revenue reaching c.£700m and strong customer expansion, plus a confident outlook and stepped-up investment plans for FY26.
JoshuaJanuary 20, 2026
Kier Group achieves net cash milestone with a record £11.6bn order book, as first-half trading sees guidance intact and cash performance significantly stronger.
JoshuaJanuary 20, 2026
Treatt’s FY25 profit fell sharply on high citrus costs & softer US demand, while a new pact governs major shareholder Döhler. Disciplined costs & growth investments aim to rebuild margins.
JoshuaJanuary 20, 2026
Flowtech's FY25 EBITDA slightly misses consensus but shows strong H2 momentum. Acquisition of Q Plus boosts European pneumatics expansion, funded via placing.
JoshuaJanuary 20, 2026
Capital Limited ends FY 2025 strong with record MSALABS performance and positive momentum heading into 2026.
JoshuaJanuary 20, 2026
GSK acquires RAPT Therapeutics for $2.2bn, gaining a long-acting food allergy drug with 12-week dosing that transforms management for high-risk patients.
JoshuaJanuary 20, 2026
Distil PLC Q3: Consumer sales surge 36% amid revenue fall, with Blavod securing US regulatory approval.
JoshuaJanuary 19, 2026
Cambridge Cognition sees 73% surge in orders and a stronger order book, setting up higher revenue for 2026 and launching a key healthcare pilot.
JoshuaJanuary 19, 2026
XP Power exits low-margin RF, opens Malaysia factory as orders rebound but revenue dips in strategic pivot.
JoshuaJanuary 19, 2026
Nexteq's FY25 revenue hits $90.2m, profit in line. Firm eyes 2026 growth with new software and DDR5 transition, despite supply chain pressures.
JoshuaJanuary 19, 2026
Fintel's £11m acquisition of Pearson Ham's insurance pricing data boosts Defaqto's software division, set to enhance AI tools and be earnings accretive from 2026, funded without equity dilution.
JoshuaJanuary 19, 2026
Pennant International's FY25 update shows stronger order book, record software ARR, and sharp debt reduction. The company eyes break-even profitability in FY26 with a clear growth plan.
JoshuaJanuary 19, 2026
SigmaRoc smashes FY25 targets: profits up, margins fatter, leverage down. Optimistic for 2026 with H2 tailwinds.
JoshuaJanuary 19, 2026
FY25 revenue up 120% to £18m with losses halved. Surface Transforms eyes EBITDA breakeven in 2026 amid operational gains.
JoshuaJanuary 19, 2026
City of London Investment Group reports H2 2025 FuM growth to $11.2bn. Strong outperformance in Emerging Markets and Listed Private Equity strategies, though net client outflows provide a note of caution.
JoshuaJanuary 19, 2026
Christie Group expects FY25 revenue >£70m & operating profit >£6.5m, smashing upgraded forecasts. A blockbuster year with robust cash.
JoshuaJanuary 19, 2026